
|Slideshows|May 10, 2017
Neuro News Roundup: Migraine & MS Risks
Author(s)Mark L. Fuerst
Research includes impact of body weight on migraine risk, effect of sleep on MS relapse, and side effects of statins in stroke survivors.
Advertisement
Three new studies in three major neurologic disorders â stroke, multiple sclerosis, and migraine â include: most stroke survivors follow their doctors' advice, but some stop taking medications due to side effects; sleep disturbance might trigger an acute exacerbation of MS; and both too much and too little weight may increase the risk of migraine.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
3
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
4
CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis
5










